Indv Ln News Today

U.S. futures for the S&P 500 were up 1.2% and futures for the Dow Jones Industrial Average rose 0.5%. Changes in futures don't necessarily predict movements...

By Anthony O. Goriainoff and Ian Walker Indivior shares rose as much as 22% after the company said that it was sounding out investors over a possible move to...

By Najat Kantouar Indivior said it has reached an agreement with Actavis Laboratories UT to resolve patent disputes regarding Actavis's Abbreviated New Drug...

By Christian Moess Laursen Indivior said the U.K. high court has removed securities claims against the company and Reckitt Benckiser in separate legal cases...

By Joe Hoppe Indivior said it has extended its relationship agreement with shareholder Scopia Capital Management, extending the board tenure of director...

By Elena Vardon Indivior swung to a pretax loss for the third quarter of 2023 on higher costs, but backed its revenue expectations for the year. The...

By Elena Vardon C4X Discovery Holdings on Tuesday said it is selling the proprietary rights to its oral Orexin-1 receptor antagonist for substance use...

By Joe Hoppe Indivior said Thursday that pretax profit and revenue for the second quarter rose on strong sales volume growth, and raised its full-year...